OP Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
OP Asset Management's BMY Position: Q1 2026 in Review
OP Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 7.1% in Q1 2026, selling an estimated $944K and leaving 212,727 shares worth $12.9M. The position accounts for 0.13% of the portfolio, ranked #107.
OP Asset Management first reported a position in BMY in Q1 2025 and has held it in 5 quarters since. The position peaked at $18.6M in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- OP Asset Management held 212,727 shares of Bristol-Myers Squibb worth $12.9M as of Q1 2026.
- OP Asset Management sold 16,194 Bristol-Myers Squibb shares in Q1 2026, an estimated $944K.
- Bristol-Myers Squibb made up 0.13% of OP Asset Management's portfolio in Q1 2026, its #107 holding.
- OP Asset Management first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 5 quarters since.
- OP Asset Management's Bristol-Myers Squibb position peaked at $18.6M in Q1 2025.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on OP Asset Management's 13F filing for Q1 2026, filed 9 Apr 2026.